![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
[Risk factors for coronary heart disease]
M Lechleitner1, J R Patsch, H Braunsteiner
1Abteilung für Klinische Atheroskleroseforschung, Universitätsklinik für Innere Medizin, Innsbruck.
Wiener Klinische Wochenschrift
|January 1, 1991
Summary
Recent studies question the link between high-density lipoprotein (HDL) cholesterol and heart health. However, major trials demonstrate intensive lipid-lowering therapy effectively reduces coronary lesions.
Area of Science:
- Epidemiology
- Cardiovascular Medicine
- Biostatistics
Context:
- Cardiovascular disease is a leading cause of death globally, with numerous risk factors.
- Recent scientific controversy questions the interpretation of epidemiological data regarding HDL cholesterol.
- Concerns exist about the cost-effectiveness of lipid-lowering interventions.
Purpose:
- To summarize recent epidemiological evidence on high-density lipoprotein (HDL) cholesterol.
- To address scientific controversy surrounding HDL cholesterol and coronary heart disease (CHD).
- To analyze the impact of lipid-lowering therapy on coronary lesions.
Summary:
- A meta-analysis of major epidemiological studies on HDL cholesterol was conducted.
- Three large studies (FATS, POSCH, CLAS) are highlighted for their findings.
- These studies demonstrate that intensive lipid-lowering therapy positively impacts coronary lesions.
Impact:
- Provides a comprehensive overview of current epidemiological evidence on HDL cholesterol.
- Addresses and clarifies recent scientific debates regarding lipid-lowering therapies.
- Reinforces the clinical benefits of intensive lipid management in cardiovascular disease prevention.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...